Test Price
2,800 AED✅ Home Collection Available
CHRNA1 Gene (Fast‑Channel Congenital Myasthenic Syndrome) Genetic Test in UAE
Executive Summary & Core Metrics
This advanced genetic test utilizes Next-Generation Sequencing (NGS) to diagnose fast‑channel congenital myasthenic syndrome associated with the CHRNA1 gene. Our ISO 9001:2015 accredited laboratory ensures diagnostic accuracy exceeding 99.9%, complemented by hospital‑grade home collection and telephonic post‑test clinical guidance.
- ✓ Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
- ✓ Premium Logistics: Paid Hospital‑Grade Home Collection via ISO Certified Cold‑Chain Home Collection and VIP Mobile Phlebotomy (Available daily from 8 AM to 11 PM).
- ✓ Clinical Guidance: Telephonic Post‑Test Clinical Guidance in result interpretation.
- ✓ Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The CHRNA1 gene test detects pathogenic variants responsible for fast‑channel congenital myasthenic syndrome, a rare neuromuscular junction disorder causing life‑threatening weakness from birth. Early molecular diagnosis is critical for guiding targeted therapeutic interventions and improving long‑term clinical outcomes.
| Feature | Our Test (NGS Panel) | Standard Single‑Gene Sequencing |
|---|---|---|
| Methodology | Next‑Generation Sequencing (NGS) with optional RNA Seq | Sanger Sequencing only |
| Analytical Sensitivity | >99.9% for SNVs, indels, copy number changes | ~99% for point mutations, limited CNV detection |
| Turnaround Time | 3 – 4 Weeks | 4 – 6 Weeks |
Physician Insight & Safety Protocols
“This test uncovers the molecular basis of congenital myasthenic syndromes. Interpretation must be integrated with clinical electrophysiology and family history; a positive result guides precision therapy, while a negative result may warrant whole‑exome sequencing. Trust the science, but lean on your neurologist for the complete picture.”
Medication & Clinical Advisory
Do not discontinue prescribed medication without consulting your doctor. Withdrawal can precipitate a myasthenic crisis. Always maintain an updated medication list for your genetic counselor.
Exclusion Criteria & Emergency Red Flags
- Exclusion: Patients without a clinical diagnosis of congenital myasthenic syndrome or family history confirmed by a geneticist.
- Exclusion: Unstable medical condition requiring immediate intensive care; genetic testing should be deferred until stabilized.
- Red Flag: Sudden worsening of swallowing, breathing, or head control – call emergency services 998 immediately.
- Red Flag: Profound hypotonia with oxyhaemoglobin desaturation despite respiratory support.
Patient FAQ & Clinical Guidance
1. What is fast‑channel congenital myasthenic syndrome caused by CHRNA1?
It is a rare genetic disorder that causes severe muscle weakness from birth due to abnormally fast closure of acetylcholine receptors.
2. How is the sample collected for this genetic test?
A simple blood draw, one drop of blood on an FTA card, or extracted DNA is collected by our certified home phlebotomy team.
3. Will I receive help understanding my test results?
Absolutely, a telephonic post‑test consultation with a clinical geneticist is included to explain your pathogenic variants and next steps.
UAE Regulatory & Data Privacy Adherence
Data Privacy & Security: DNA Labs UAE strictly complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data is encrypted, access‑controlled, and processed solely for diagnostic purposes with explicit patient consent.
Clinical Safety & Liability: Patient safety and clinical governance adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability, ensuring full accountability and transparent medical practices.
Accreditation: Our laboratory operations are ISO 9001:2015 certified (Cert: INT/EGQ/2509DA/3139), guaranteeing international standards of quality and precision.
Clinical & Logistical Metadata
| Test Name | CHRNA1 Gene (Fast‑Channel Congenital Myasthenic Syndrome) Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3 – 4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood, FTA Card, or Extracted DNA |
| Methodology Used | Next-Generation Sequencing (NGS) with optional RNA Sequencing |
| ICD-10-CM Code | G70.2 (Congenital myasthenic syndromes) |
| LOINC Code | 94883-6 (Neuromuscular junction gene panel) |
| DHA License & Address | DHA Facility License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians